140 related articles for article (PubMed ID: 10744748)
21. Overexpression of the Shb SH2 domain-protein in insulin-producing cells leads to altered signaling through the IRS-1 and IRS-2 proteins.
Welsh N; Makeeva N; Welsh M
Mol Med; 2002 Nov; 8(11):695-704. PubMed ID: 12520086
[TBL] [Abstract][Full Text] [Related]
22. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
Guvakova MA; Surmacz E
Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
[TBL] [Abstract][Full Text] [Related]
23. Activation of the insulin-like growth factor 1 signaling pathway by the antiapoptotic agents aurintricarboxylic acid and evans blue.
Beery R; Haimsohn M; Wertheim N; Hemi R; Nir U; Karasik A; Kanety H; Geier A
Endocrinology; 2001 Jul; 142(7):3098-107. PubMed ID: 11416032
[TBL] [Abstract][Full Text] [Related]
24. Regulation of insulin/insulin-like growth factor-1 signaling by proteasome-mediated degradation of insulin receptor substrate-2.
Rui L; Fisher TL; Thomas J; White MF
J Biol Chem; 2001 Oct; 276(43):40362-7. PubMed ID: 11546773
[TBL] [Abstract][Full Text] [Related]
25. Pertussis toxin-sensitive and insensitive intracellular signalling pathways in undifferentiated 3T3-L1 cells stimulated by insulin converge with phosphatidylinositol 3-kinase upstream of the Ras mitogen-activated protein kinase cascade.
Uehara T; Tokumitsu Y; Nomura Y
Eur J Biochem; 1999 Feb; 259(3):801-8. PubMed ID: 10092867
[TBL] [Abstract][Full Text] [Related]
26. Differences in signaling properties of the cytoplasmic domains of the insulin receptor and insulin-like growth factor receptor in 3T3-L1 adipocytes.
Ursø B; Cope DL; Kalloo-Hosein HE; Hayward AC; Whitehead JP; O'Rahilly S; Siddle K
J Biol Chem; 1999 Oct; 274(43):30864-73. PubMed ID: 10521479
[TBL] [Abstract][Full Text] [Related]
27. Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes.
Fasshauer M; Klein J; Kriauciunas KM; Ueki K; Benito M; Kahn CR
Mol Cell Biol; 2001 Jan; 21(1):319-29. PubMed ID: 11113206
[TBL] [Abstract][Full Text] [Related]
28. Insulin and interleukin-4 induce desensitization to the mitogenic effects of insulin-like growth factor-I. Pivotal role for insulin receptor substrate-2.
Haddad TC; Conover CA
J Biol Chem; 1997 Aug; 272(31):19525-31. PubMed ID: 9235956
[TBL] [Abstract][Full Text] [Related]
29. Tyrosine phosphorylation-dependent and -independent role of Shc in the regulation of IGF-1-induced mitogenesis and glycogen synthesis.
Sasaoka T; Ishiki M; Wada T; Hori H; Hirai H; Haruta T; Ishihara H; Kobayashi M
Endocrinology; 2001 Dec; 142(12):5226-35. PubMed ID: 11713219
[TBL] [Abstract][Full Text] [Related]
30. Insulin-like growth factor-I (IGF-I)-dependent activation of pp42/44 mitogen-activated protein kinase occurs independently of IGF-I receptor kinase activation and IRS-1 tyrosine phosphorylation.
Yau L; Lukes H; McDiarmid H; Werner J; Zahradka P
Eur J Biochem; 1999 Dec; 266(3):1147-57. PubMed ID: 10583412
[TBL] [Abstract][Full Text] [Related]
31. Different pathways of postreceptor desensitization following chronic insulin treatment and in cells overexpressing constitutively active insulin receptors.
Inoue G; Cheatham B; Kahn CR
J Biol Chem; 1996 Nov; 271(45):28206-11. PubMed ID: 8910437
[TBL] [Abstract][Full Text] [Related]
32. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells.
Kim B; Leventhal PS; White MF; Feldman EL
Endocrinology; 1998 Dec; 139(12):4881-9. PubMed ID: 9832424
[TBL] [Abstract][Full Text] [Related]
33. Src family tyrosine kinases participate in insulin-like growth factor I mitogenic signaling in 3T3-L1 cells.
Boney CM; Sekimoto H; Gruppuso PA; Frackelton AR
Cell Growth Differ; 2001 Jul; 12(7):379-86. PubMed ID: 11457735
[TBL] [Abstract][Full Text] [Related]
34. GTK tyrosine kinase-induced alteration of IRS-protein signalling in insulin producing cells.
Annerén C; Welsh M
Mol Med; 2002 Nov; 8(11):705-13. PubMed ID: 12520087
[TBL] [Abstract][Full Text] [Related]
35. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5.
Ewton DZ; Coolican SA; Mohan S; Chernausek SD; Florini JR
J Cell Physiol; 1998 Oct; 177(1):47-57. PubMed ID: 9731744
[TBL] [Abstract][Full Text] [Related]
36. Tumor necrosis factor alpha-mediated insulin resistance, but not dedifferentiation, is abrogated by MEK1/2 inhibitors in 3T3-L1 adipocytes.
Engelman JA; Berg AH; Lewis RY; Lisanti MP; Scherer PE
Mol Endocrinol; 2000 Oct; 14(10):1557-69. PubMed ID: 11043572
[TBL] [Abstract][Full Text] [Related]
37. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.
Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways.
Sasaoka T; Ishiki M; Sawa T; Ishihara H; Takata Y; Imamura T; Usui I; Olefsky JM; Kobayashi M
Endocrinology; 1996 Oct; 137(10):4427-34. PubMed ID: 8828504
[TBL] [Abstract][Full Text] [Related]
39. Role of the Grb2-associated binder 1/SHP-2 interaction in cell growth and transformation.
Holgado-Madruga M; Wong AJ
Cancer Res; 2004 Mar; 64(6):2007-15. PubMed ID: 15026337
[TBL] [Abstract][Full Text] [Related]
40. Insulin receptor substrate 1 mediates insulin and insulin-like growth factor I-stimulated maturation of Xenopus oocytes.
Chuang LM; Myers MG; Seidner GA; Birnbaum MJ; White MF; Kahn CR
Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5172-5. PubMed ID: 7685118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
